 
  Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Medical Therapies of Cushing's Disease-Part 1
Endocrinology and metabolism clinics of North America. 2025 Dec ; 54:609-626
Medical Therapies of Cushing's Disease-Part 2
Endocrinology and metabolism clinics of North America. 2025 Dec ; 54:627-635
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study
Pituitary. 2025 Oct 22; 28:116
RAGE-mediated activation of the formin DIAPH1 and human macrophage inflammation are inhibited by a small molecule antagonist
Cell chemical biology. 2025 Oct 16; 32:1221-1234.e8
Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
Arteriosclerosis, thrombosis, and vascular biology. 2025 Oct 16;
Development and validation of clinical screening systems for Cushing disease in the United States
Pituitary. 2025 Oct 10; 28:108
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease
Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025 Oct ; 21:e70765
Current Concepts in Revascularization for Ischemic Heart Disease With Reduced Ejection Fraction
Circulation. Cardiovascular interventions. 2025 Sep 15; e014625